525 related articles for article (PubMed ID: 20823436)
1. Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains.
van Gils EJ; Veenhoven RH; Hak E; Rodenburg GD; Keijzers WC; Bogaert D; Trzcinski K; Bruin JP; van Alphen L; van der Ende A; Sanders EA
JAMA; 2010 Sep; 304(10):1099-106. PubMed ID: 20823436
[TBL] [Abstract][Full Text] [Related]
2. Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial.
van Gils EJ; Veenhoven RH; Hak E; Rodenburg GD; Bogaert D; Ijzerman EP; Bruin JP; van Alphen L; Sanders EA
JAMA; 2009 Jul; 302(2):159-67. PubMed ID: 19584345
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae.
Dagan R; Juergens C; Trammel J; Patterson S; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA
J Infect Dis; 2015 Apr; 211(7):1144-53. PubMed ID: 25355940
[TBL] [Abstract][Full Text] [Related]
4. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.
Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP
Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290
[TBL] [Abstract][Full Text] [Related]
5. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era.
Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C
Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249
[TBL] [Abstract][Full Text] [Related]
6. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children.
Tocheva AS; Jefferies JM; Rubery H; Bennett J; Afimeke G; Garland J; Christodoulides M; Faust SN; Clarke SC
Vaccine; 2011 Jun; 29(26):4400-4. PubMed ID: 21504773
[TBL] [Abstract][Full Text] [Related]
7. Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age.
Nunes MC; Jones SA; Groome MJ; Kuwanda L; Van Niekerk N; von Gottberg A; de Gouveia L; Adrian PV; Madhi SA
Vaccine; 2015 Jan; 33(5):628-34. PubMed ID: 25541213
[TBL] [Abstract][Full Text] [Related]
8. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers.
Dagan R; Givon-Lavi N; Zamir O; Fraser D
Pediatr Infect Dis J; 2003 Jun; 22(6):532-40. PubMed ID: 12799510
[TBL] [Abstract][Full Text] [Related]
9. Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine.
Lee JK; Yun KW; Choi EH; Kim SJ; Lee SY; Lee HJ
J Korean Med Sci; 2017 Sep; 32(9):1431-1439. PubMed ID: 28776337
[TBL] [Abstract][Full Text] [Related]
10. The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial.
Dagan R; Givon-Lavi N; Porat N; Greenberg D
Vaccine; 2012 Jul; 30(34):5132-40. PubMed ID: 22683519
[TBL] [Abstract][Full Text] [Related]
11. Streptococcus pneumoniae serotype 19A: worldwide epidemiology.
Isturiz R; Sings HL; Hilton B; Arguedas A; Reinert RR; Jodar L
Expert Rev Vaccines; 2017 Oct; 16(10):1007-1027. PubMed ID: 28783380
[TBL] [Abstract][Full Text] [Related]
12. The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey.
Soysal A; Karabağ-Yılmaz E; Kepenekli E; Karaaslan A; Cagan E; Atıcı S; Atınkanat-Gelmez G; Boran P; Merdan S; Hasdemir U; Söyletir G; Bakır M
Vaccine; 2016 Jul; 34(33):3894-900. PubMed ID: 27269059
[TBL] [Abstract][Full Text] [Related]
13. Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme.
Wouters I; Van Heirstraeten L; Desmet S; Blaizot S; Verhaegen J; Goossens H; Van Damme P; Malhotra-Kumar S; Theeten H;
Vaccine; 2018 Jan; 36(1):15-22. PubMed ID: 29180027
[TBL] [Abstract][Full Text] [Related]
14. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
[TBL] [Abstract][Full Text] [Related]
15. Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine.
Wroe PC; Lee GM; Finkelstein JA; Pelton SI; Hanage WP; Lipsitch M; Stevenson AE; Rifas-Shiman SL; Kleinman K; Dutta-Linn MM; Hinrichsen VL; Lakoma M; Huang SS
Pediatr Infect Dis J; 2012 Mar; 31(3):249-54. PubMed ID: 22173142
[TBL] [Abstract][Full Text] [Related]
16. The impact of pneumococcal conjugate vaccines on serotype 19A nasopharyngeal carriage.
Tin Tin Htar M; Sings HL; Syrochkina M; Taysi B; Hilton B; Schmitt HJ; Gessner BD; Jodar L
Expert Rev Vaccines; 2019 Dec; 18(12):1243-1270. PubMed ID: 31587592
[No Abstract] [Full Text] [Related]
17. Pneumococcal carriage among children under five in Accra, Ghana, five years after the introduction of pneumococcal conjugate vaccine.
Dayie NTKD; Tettey EY; Newman MJ; Bannerman E; Donkor ES; Labi AK; Slotved HC
BMC Pediatr; 2019 Sep; 19(1):316. PubMed ID: 31488088
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster.
Russell FM; Carapetis JR; Satzke C; Tikoduadua L; Waqatakirewa L; Chandra R; Seduadua A; Oftadeh S; Cheung YB; Gilbert GL; Mulholland EK
Clin Vaccine Immunol; 2010 Dec; 17(12):1970-6. PubMed ID: 20943882
[TBL] [Abstract][Full Text] [Related]
19. Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia.
Parra EL; De La Hoz F; Díaz PL; Sanabria O; Realpe ME; Moreno J
Vaccine; 2013 Aug; 31(37):4033-8. PubMed ID: 23680440
[TBL] [Abstract][Full Text] [Related]
20. Streptococcus pneumoniae nasopharyngeal carriage in children attending day-care centers in the central region of Portugal, in the era of 7-valent pneumococcal conjugate vaccine.
Rodrigues F; Nunes S; Sá-Leão R; Gonçalves G; Lemos L; de Lencastre H
Microb Drug Resist; 2009 Dec; 15(4):269-77. PubMed ID: 19857133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]